Results 221 to 230 of about 1,399,259 (268)
Some of the next articles are maybe not open access.

Low grade gliomas

2022
Low grade gliomas concern grade I and grade II tumors. The only grade one tumor is the pilocytic astrocytoma. This is a well-defined tumor with characteristic histology, often accompanied by a cyst. GKNS has been used in surgically inaccessible tumors since 1994.
openaire   +2 more sources

A low-grade extraskeletal osteosarcoma

Skeletal Radiology, 2003
The case of a 35-year-old woman with low-grade extraskeletal osteosarcoma of the left leg is presented. Radiographs showed peripheral ossification of the lesion, suggesting myositis ossificans. Most of the tumor was composed of cartilage, and the cellularity and cell atypia of the proliferating chondrocytes were mild to moderate. In the periphery, bone
Kyoji, Okada   +5 more
openaire   +2 more sources

Low-grade gliomas

Current Treatment Options in Oncology, 2001
Low-grade gliomas are uncommon primary brain tumors classified as histologic grades I or II in the World Health Organization (WHO) classification. The most common variants are pilocytic and low-grade astrocytomas, oligodendrogliomas, and mixed oligo-astrocytomas located in the cerebral hemispheres.
openaire   +2 more sources

Chemotherapy in low-grade gliomas

Current Opinion in Oncology, 2012
This review summarizes the recent studies in adults' diffuse low-grade gliomas (LGGs) chemotherapy, including response assessment and potential predictive biomarkers of chemosensitivity.Recent studies have confirmed that chemotherapy is an interesting treatment option in LGGs.
Aurélien, Viaccoz   +2 more
openaire   +2 more sources

Low-Grade Glioma

2014
Low-grade gliomas are slower growing than their high-grade counterparts. They account for 10-20 % of all primary brain tumors. Median survival is between 4.7 and 9.8 years. The goal of treatment is to prolong overall survival while maintaining good quality of life (QOL). Recent data favors early surgical resection.
Priya, Kumthekar   +2 more
openaire   +2 more sources

Low-grade gliomas

2012
Abstract Diffuse infiltrative low-grade gliomas of the cerebral hemispheres in the adult are a group of tumors with distinct clinical, histological, and molecular characteristics, and there are still controversies regarding management. The scientific evidence of papers collected from the literature was evaluated and graded according to European ...
R, Rudà, E, Trevisan, R, Soffietti
openaire   +2 more sources

Low-Grade Fibromyxoid Sarcoma

Oncology, 2000
Described is a low-grade fibromyxoid sarcoma (LGFMS) of the abdominal wall muscles in a 38-year-old black woman. There was no evidence of metastatic disease. A 5.2-kg LGFMS – the largest case ever reported – was resected. One year after surgery, the patient is alive without any sign of local recurrence or distant metastasis.
M R, van den Bossche, H, Van Mieghem
openaire   +2 more sources

Low-grade gliomas in adults

Current Treatment Options in Neurology, 2008
Making treatment decisions for patients with infiltrating low-grade gliomas (LGGs) is challenging. Patients frequently present with seizures and usually have little or no neurologic deficit. In this younger and relatively well patient population, despite the potential for significant morbidity, we believe that surgical resection, radiation therapy, and
Sandeep, Mittal   +2 more
openaire   +2 more sources

Dedifferentiation of Low Grade Chondrosarcomas

Clinical Orthopaedics and Related Research, 1977
In four unusual cases where a low-grade chondrosarcoma suddenly dedifferentiated into a florid, highly-malignant fibrosarcoma, the average survival was 12 months (range 5-18 months). The surgical treatment of chondrosarcoma consists of a primary excisional biopsy, and if dedifferentiation to fibrosarcoma is seen, radical excision and chemotherapy or ...
G B, McFarland, L M, McKinley, R J, Reed
openaire   +2 more sources

Low-grade and anaplastic oligodendroglioma

2016
Anaplastic oligodendrogliomas have long attracted interest because of their sensitivity to chemotherapy, in particular in the subset of 1p/19q co-deleted tumors. Recent molecular studies have shown that all 1p/19q co-deleted tumors have IDH mutations and most of them also have TERT mutations.
van den Bent, Martin   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy